You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, January 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Immunology
 •Immunologic Disorders
 •Neurology
 •Neuro-ophthalmology
 •Ophthalmological Disorders, Other
 •Alert me on articles by topic

Is Neuromyelitis Optica Eyeing a Distinct Path From Multiple Sclerosis?

Christopher C. Glisson, DO; Steven L. Galetta, MD

Arch Ophthalmol. 2008;126(1):128-129.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Devic1 originally defined neuromyelitis optica (NMO) in the late 19th century as an acute monophasic syndrome characterized by bilateral (or rapidly sequential) optic neuritis and severe myelitis; attacks were limited to the optic nerve and spinal cord and resulted in significant disability. Subsequently, variations in clinical presentation, frequency of relapses, and degree of severity have been reported.2-7 Since 1999, 2 versions of standardized clinical criteria for the diagnosis of NMO have been suggested,8-9 and further revisions are likely in the near future. Given the lack of precisely defined clinical and diagnostic features, controversy has emerged regarding the potential relationship of NMO with other inflammatory conditions of the central nervous system, most notably multiple sclerosis (MS). The need to clearly distinguish between these conditions at the time of diagnosis, however, may be critical, given the perceived deleterious effect of NMO on neurologic function . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLE

Clinical Course of Optic Neuritis in Patients With Relapsing Neuromyelitis Optica
Regina Maria Papais-Alvarenga, Sandro Carvalho Carellos, Marcos Papais Alvarenga, Clarice Holander, Roberly Pinto Bichara, and Luiz Claudio Santos Thuler
Arch Ophthalmol. 2008;126(1):12-16.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.